Quanergy Systems (QNGWQ) S-4/A 21 Sep 21 Registration of securities issued in business combination transactions (amended) Financial data

Cover Page

Cover Page	6 Months Ended
	Jun. 30, 2021
Entity Information [Line Items]
Document Type	S-4/A
Amendment Flag	true
Amendment Description	Amendment No. 1
Entity Registrant Name	CITIC Capital Acquisition Corp.
Entity Central Index Key	0001794621
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Small Business	true

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Assets:
Cash	$ 126,622	$ 981,606	$ 300,000
Prepaid expense	248,103	16,589
Total current assets	374,725	998,195	300,000
Deferred offering costs			87,885
Investments held in Trust Account	277,859,656	277,845,876
Total assets	278,234,381	278,844,071	387,885
Liabilities [Abstract]
Accounts payable and accrued expense	2,839,039	28,509
Due to related parties	385,366	55,931	85,851
Advance from Sponsor			300,000
Total current liabilities	3,224,405	84,440	385,851
Deferred underwriting commissions	9,660,000	9,660,000
Warrant Liability	22,975,200	36,620,000
Total liabilities	35,859,605	46,364,440	385,851
Commitments and Contingencies
Shareholders' equity:
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding
Additional paid-in capital	5,633,547	15,528,588	24,310
Retained earnings (accumulated deficit)	(634,617)	(10,529,762)	(22,966)
Total shareholders' equity	5,000,006	5,000,001	2,034
Total liabilities and shareholders' equity	278,234,381	278,844,071	387,885
Class A Common Stock
Liabilities [Abstract]
Class A ordinary shares subject to possible redemption, $0.0001 par value; 23,737,477 shares and 22,747,963 shares at June 30, 2021 and December 31, 2020, respectively (at redemption value of $10.00 per share)	237,374,770	227,479,630
Shareholders' equity:
Ordinary shares	386	485
Total shareholders' equity	386	485
Class B common stock
Shareholders' equity:
Ordinary shares	690	690	690
Total shareholders' equity	$ 690	$ 690	$ 690

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Ordinary shares subject to possible redemption	23,737,477	22,747,963
Preferred shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred shares, shares authorized	1,000,000	1,000,000	1,000,000
Preferred shares, shares Issued	0	0	0
Preferred shares, shares outstanding	0	0	0
Class A Common Stock
Ordinary shares, par value	$ 0.0001	$ 0.0001
Ordinary shares subject to possible redemption	23,737,477	22,747,963	0
Ordinary shares, redemption price per share	$ 10	$ 10	$ 10
Common shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common shares, shares authorized	200,000,000	200,000,000	200,000,000
Common shares, shares issued	3,862,523	4,852,037	0
Common shares, shares outstanding	3,862,523	4,852,037	0
Class B common stock
Common shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common shares, shares authorized	20,000,000	20,000,000	20,000,000
Common shares, shares issued	6,900,000	6,900,000	6,900,000
Common shares, shares outstanding	6,900,000	6,900,000	6,900,000

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	3 Months Ended		4 Months Ended	6 Months Ended		12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2019	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
General and administrative expenses	$ 3,099,387	$ 165,209	$ 22,966	$ 3,763,435	$ 213,745	$ 562,220
Loss from operations	(3,099,387)	(165,209)	(22,966)	(3,763,435)	(213,745)	(562,220)
Other Income (expense):
Interest income and realized gain from sale from investments held in Trust Account	6,928	69,247	0	13,780	1,831,868	1,845,877
Warrant issuance costs		(343)			(1,044,453)	(1,044,453)
Excess of the fair value of private placement warrants over cash received					(2,932,800)	(2,932,800)
Unrealized gain (loss) on fair value changes of warrants	1,216,400	1,542,800		13,644,800	12,792,000	(7,813,200)
Net income (loss)	$ (1,876,059)	$ 1,446,495	$ (22,966)	$ 9,895,145	$ 10,432,870	$ (10,506,796)
Class A Common Stock
Other Income (expense):
Weighted average shares outstanding of ordinary shares, basic and diluted	27,600,000	27,600,000	0	27,600,000	27,600,000	27,600,000
Basic and diluted net income (loss) per ordinary share	$ 0	$ 0	$ 0	$ 0	$ 0.02	$ 0.07
Class B common stock
Other Income (expense):
Weighted average shares outstanding of ordinary shares, basic and diluted	6,900,000	6,687,363	6,000,000	6,900,000	6,687,363	6,794,262
Basic and diluted net income (loss) per ordinary share	$ (0.27)	$ 0.21	$ 0	$ 1.43	$ 1.29	$ (1.82)

Condensed Statements of Changes

Condensed Statements of Changes in Shareholders' Equity - USD ($)	Total	IPO [Member]	Class A Common Stock	Class A Common StockIPO [Member]	Class B common stock	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member]IPO [Member]	Retained Earnings (Accumulated Deficit) [Member]
Beginning balance at Sep. 08, 2019
Beginning balance, shares at Sep. 08, 2019
Issuance of Class B ordinary shares to Sponsor at approximately $0.004 per share	25,000				$ 690	24,310
Issuance of Class B ordinary shares to Sponsor at approximately $0.004 per share, shares					6,900,000
Net income (loss)	(22,966)							(22,966)
Ending balance at Dec. 31, 2019	2,034				$ 690	24,310		(22,966)
Ending balance, shares at Dec. 31, 2019					6,900,000
Sale of Units		$ 257,646,000		$ 2,760			$ 257,643,240
Sale of Units, shares				27,600,000
Offering costs charged to the shareholders' equity	(14,656,790)					(14,656,790)
Change in Class A ordinary shares subject to possible redemption	(246,977,618)		$ (2,470)			(246,975,148)
Change in Class A ordinary shares subject to possible redemption, shares			(24,697,762)
Net income (loss)	8,986,375							8,986,375
Ending balance at Mar. 31, 2020	5,000,001		$ 290		$ 690	(3,964,388)		8,963,409
Ending balance, shares at Mar. 31, 2020			2,902,238		6,900,000
Beginning balance at Dec. 31, 2019	2,034				$ 690	24,310		(22,966)
Beginning balance, shares at Dec. 31, 2019					6,900,000
Net income (loss)	10,432,870
Ending balance at Jun. 30, 2020	5,000,001		$ 276		$ 690	(5,410,869)		10,409,904
Ending balance, shares at Jun. 30, 2020			2,758,070		6,900,000
Beginning balance at Dec. 31, 2019	2,034				$ 690	24,310		(22,966)
Beginning balance, shares at Dec. 31, 2019					6,900,000
Sale of Units	0	$ 257,646,000		$ 2,760			$ 257,643,240
Sale of Units, shares				27,600,000
Offering costs charged to the shareholders' equity	(14,661,607)					(14,661,607)
Change in Class A ordinary shares subject to possible redemption	(227,479,630)		$ (2,275)			(227,477,355)
Change in Class A ordinary shares subject to possible redemption, shares			(22,747,963)
Net income (loss)	(10,506,796)							(10,506,796)
Ending balance at Dec. 31, 2020	5,000,001		$ 485		$ 690	15,528,588		(10,529,762)
Ending balance, shares at Dec. 31, 2020			4,852,037		6,900,000
Beginning balance at Mar. 31, 2020	5,000,001		$ 290		$ 690	(3,964,388)		8,963,409
Beginning balance, shares at Mar. 31, 2020			2,902,238		6,900,000
Offering costs charged to the shareholders' equity	(5,160)					(5,160)
Reclassification of offering costs related to warrants	343					343
Change in Class A ordinary shares subject to possible redemption	(1,441,678)		$ (14)			(1,441,664)
Change in Class A ordinary shares subject to possible redemption, shares			(144,168)
Net income (loss)	1,446,495							1,446,495
Ending balance at Jun. 30, 2020	5,000,001		$ 276		$ 690	(5,410,869)		10,409,904
Ending balance, shares at Jun. 30, 2020			2,758,070		6,900,000
Beginning balance at Dec. 31, 2020	5,000,001		$ 485		$ 690	15,528,588		(10,529,762)
Beginning balance, shares at Dec. 31, 2020			4,852,037		6,900,000
Change in Class A ordinary shares subject to possible redemption	(11,771,200)		$ (118)			(11,771,082)
Change in Class A ordinary shares subject to possible redemption, shares			(1,177,120)
Net income (loss)	11,771,204							11,771,204
Ending balance at Mar. 31, 2021	5,000,005		$ 367		$ 690	3,757,506		1,241,442
Ending balance, shares at Mar. 31, 2021			3,674,917		6,900,000
Beginning balance at Dec. 31, 2020	5,000,001		$ 485		$ 690	15,528,588		(10,529,762)
Beginning balance, shares at Dec. 31, 2020			4,852,037		6,900,000
Offering costs charged to the shareholders' equity	(14,661,607)
Net income (loss)	9,895,145
Ending balance at Jun. 30, 2021	5,000,006		$ 386		$ 690	5,633,547		(634,617)
Ending balance, shares at Jun. 30, 2021			3,862,523		6,900,000
Beginning balance at Mar. 31, 2021	5,000,005		$ 367		$ 690	3,757,506		1,241,442
Beginning balance, shares at Mar. 31, 2021			3,674,917		6,900,000
Change in Class A ordinary shares subject to possible redemption	1,876,060		$ 19			1,876,041
Change in Class A ordinary shares subject to possible redemption, shares			187,606
Net income (loss)	(1,876,059)							(1,876,059)
Ending balance at Jun. 30, 2021	$ 5,000,006		$ 386		$ 690	$ 5,633,547		$ (634,617)
Ending balance, shares at Jun. 30, 2021			3,862,523		6,900,000

Condensed Statements of Chang_2

Condensed Statements of Changes in Shareholders' Equity (Parenthetical)	Dec. 31, 2020$ / shares
Sponsor [Member]
Shares Issued, Price Per Share	$ 0.004

Condensed Statement of Cash Flo

Condensed Statement of Cash Flows - USD ($)	3 Months Ended	4 Months Ended	6 Months Ended		9 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Jun. 30, 2021	Jun. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
Cash Flows from Operating Activities:
Net income (loss)	$ 8,986,375	$ (22,966)	$ 9,895,145	$ 10,432,870	$ (814,819)	$ (10,506,796)
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on investment held in Trust Account			(13,780)	(474,758)
Realized gain from sale of marketable securities				(1,357,111)
Realized gain and interest earned on investment held in Trust Account						(1,845,876)
Excess of the fair value of private placement warrants over cash received	2,932,800			2,932,800	2,932,800	2,932,800
Warrant issuance costs	1,044,453			1,044,453	1,044,453	1,044,453
Unrealized gain/loss on fair value changes of warrants	(11,249,200)		(13,644,800)	(12,792,000)	(1,705,600)	7,813,200
Changes in current assets and current liabilities:
Prepaid assets			(231,514)	(86,835)		(16,589)
Accounts payable and accrued expense			2,810,530	79,905		28,509
Due to related parties		22,966	329,435	25,795		10,080
Net cash used in operating activities		0	(854,984)	(194,881)		(540,219)
Cash Flows from Investing Activities:
Purchase of investment held in Trust Account				(553,609,410)		(276,000,000)
Proceeds from sale of investment held in Trust Account				277,609,410
Net cash used in investing activities				(276,000,000)		(276,000,000)
Cash Flows from Financing Activities:
Proceeds from Initial Public Offering, net of underwriters' fees			276,000,000	276,000,000		276,000,000
Proceeds from private placement				7,520,000		7,520,000
Repayment of Sponsor loan		300,000		(300,000)		(300,000)
Payments of offering costs			0	(5,996,390)		(5,998,175)
Net cash provided by financing activities		300,000	0	277,226,985		277,221,825
Net Change in Cash		300,000	(854,984)	1,056,604		681,606
Cash – Beginning	$ 300,000		981,606	300,000	$ 300,000	300,000
Cash – Ending		300,000	126,622	1,356,604		981,606
Supplemental Disclosure of Non-cash Financing Activities:
Deferred underwriting commissions charged to additional paid in capital			0	9,660,000		9,660,000
Deferred offering costs paid by sponsor in exchange for founder shares		25,000
Original value of Class A ordinary shares subject to possible redemption				234,052,236		234,052,236
Change in value of Class A ordinary shares subject to possible redemption			$ 9,895,140	14,367,403		(6,572,606)
Initial classification of warrant liability				25,874,000		$ 28,806,800
Increase in due to related party for deferred offering costs		$ 62,885
Increase in accounts payable for deferred offering costs				$ 1,785

Description of Organization and

Description of Organization and Business Operations	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Organization and Business Operations	Note 1—Description of Organization and Business Operations Organization and General CITIC Capital Acquisition Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on September 9, 2019. The Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). Although the Company is not limited to a p a industry As of June 30, 2021, the Company had not commenced any operations. All activity through June 30, 2021 relates to the Company’s formation, the initial public offering described below, and, since the completion of the Initial Public Offering (“IPO”) as defined below, searching for a target to consummate a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO and will recognize changes in the fair value of warrant liability as other income (expense). The Company’s sponsor is CITIC Capital Acquisition LLC, a Cayman Islands limited liability company (the “Sponsor”) . Financing The registration statement for the Company’s Initial Public Offering (as defined below) was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on February 10, 2020. On February 13, 2020, the Company consummated its Initial Public Offering (the “Initial Public Offering”) of June 30, 2021 , Trust Account Upon the closing of the Initial Public Offering, $276 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering, including the proceeds of the Private Placement Warrants, was held in a trust account (the “Trust Account”), located in the United States at J.P. Morgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, of 1940, as amended (the “Investment Company Act”) having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 Initial Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete an initial Business Combination with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the amount of any deferred underwriting discount held in the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the Initial Public Offering (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro-rata per-share Notwithstanding the foregoing, the Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, officers and directors (the “initial shareholders”) have agreed, pursuant to a written agreement with the Company, that they will not propose any amendment to the Amended and Restated Memorandum and Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering (the “Combination Period”), which is February 13, 2022, or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares upon approval of any such amendment at a per-share price, payable The Company will have 24 months from the closing of the Initial Public Offering to complete its initial Business Combination. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share On June 21, 2021, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among the Company, CITIC Capital Merger Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of the Company (“Merger Sub”), and Quanergy Systems, Inc., a Delaware corporation (“Quanergy”). At the closing of the transactions contemplated by the Merger Agreement (the “Closing”), upon the terms and subject to the conditions of the Merger Agreement, in accordance with the Delaware General Corporation Law, as amended (the “DGCL”), Merger Sub will merge with and into Quanergy, the separate corporate existence of Merger Sub will cease and Quanergy will be the surviving corporation and a wholly owned subsidiary of the Company (the “Merger”); as a result of the Merger, among other things, in the aggregate, a number of the Company’s ordinary shares (or a number shares of the Company’s common stock after its Domestication (as defined below), the “Quanergy PubCo common stock”) equal to the quotient obtained by dividing (x) $970,000,000 by (y) $10.00 will be issued or issuable to holders of outstanding Quanergy capital stock, including any shares of Quanergy capital stock issued or issuable pursuant to exercise or conversion of any warrants or convertible notes, and Quanergy equity awards, calculated using the treasury stock method of accounting; and upon the effective time of the Merger (the “Effective Time”), the Company will immediately be renamed “Quanergy Systems, Inc.” The Agreement contains customary representations and warranties, covenants, closing conditions, termination fee provisions and other terms relating to the initial Business Combination and the other transactions contemplated thereby. The Merger Agreement is subject to the satisfaction or waiver of certain customary closing conditions, including, among others, (i) approval of the Business Combination and related agreements and transactions by the respective shareholders of the Company and Quanergy, (ii) effectiveness of the proxy / registration statement on Form S-4 Other conditions to Quanergy’s obligations to consummate the Merger include, among others, that as of the Closing, (i) the Company’s jurisdiction of incorporation will be changed from the Cayman Islands to the State of Delaware (the “Domestication”), and (ii) the amount of cash available in (x) the Trust Account, following the extraordinary general meeting, into which substantially all of the proceeds of the Company’s initial public offering and private placements of its warrants have been deposited for the benefit of the Company, certain of its public shareholders and the underwriters of the Company’s initial public offering, after deducting the amount required to satisfy the Company’s obligations to its shareholders (if any) that exercise their rights to redeem their Class A Ordinary Shares pursuant to the Companies Act (as revised) of the Cayman Islands the Company’s Amended and Restated Memorandum and Articles of Association ( the “Cayman Constitutional Documents”) (the “Trust Amount”) plus (y) the PIPE Investment (as defined below), is at least equal to $175,000,000. The Company has entered into subscription agreements (the “Subscription Agreements”) with certain institutional and accredited investors, including, among others, certain existing equityholders of Quanergy (the “PIPE Investors”), pursuant to which the PIPE Investors agreed to purchase, in the aggregate common t”). Liquidity A s of June 30, 2021 , the Company had cash outside the Trust Account of $126,622 available for working capital needs. All cash and securities held in the Trust Account are generally unavailable for the Company’s use, prior to an initial Business Combination, and are restricted for use either in a Business Combination or to redeem ordinary shares. As of June 30, 2021 Through June 30, 2021 , The Company anticipates that the $126,622 outside of the Trust Account as of June 30, 2021, as well as the Working Capital Loans (as defined in Note 4), will be sufficient to allow the Company to operate for at least as of February 13, 2022, assuming that a Business Combination is not consummated before February 13, 2022. In addition, on June 21, 2021, the Company has entered into the Subscription Agreements with PIPE Investors, pursuant to which the PIPE Investors agreed to purchase, in the aggregate, 4,000,000 shares of Quanergy PubCo common stock at $10.00 per share for an aggregate commitment amount of $40 million. The PIPE Investment Amounts will be used to pay the expenses related to the Business Combination with Quanergy. The Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the Company’s estimates of the costs of undertaking in-depth Going Concern In connection with the Company’s assessment of going concern considerations in accordance with FASB’s Accounting Standards Update (“ASU”) 2014-15, Business Combination by February 13, 2022, then the Company will cease all operations except for the purpose of liquidating. The date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after June 30, 2021.	Note 1—Description of Organization and Business Operations Organization and General CITIC Capital Acquisition Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on September 9, 2019. The Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company intends to focus its search on the energy efficiency, clean technology and sustainability sectors. The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies . As of December 31, 2020, the Company had not commenced any operations. All activity through December 31, 2020 relates to the Company’s formation, the initial public offering described below, and, since the completion of the initial public offering, searching for a target to consummate a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income The Company’s sponsor is CITIC Capital Acquisition LLC, a Cayman Islands limited liability company (the “Sponsor”). Financing The registration statement for the Company’s Initial Public Offering (as defined below) was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on February 10, 2020. On February 13, 2020, the Company consummated its Initial Public Offering (the “Initial Public Offering”) of 27,600,000 units (each, a “Unit” and collectively, the “Units”), including 3,600,000 Units issued pursuant to the exercise in full of the underwriters’ over-allotment option, at $10.00 per Unit, generating gross proceeds of $276 million, and incurring offering costs of approximately $15.7 million, inclusive of $9.66 million in deferred underwriting commissions (Note 4). Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7.52 million warrants (the “Private Placement Warrants”), at a price of $1.00 per warrant (Note 5), generating gross proceeds of $7.52 million. The Company intends to finance its initial Business Combination with the proceeds from the Initial Public Offering and private placement. Upon the closing of the Initial Public Offering and the private placement, $276 million was held in a trust account (discussed below). As of December 31, 2020, the Company had approximately $0.98 million in cash held outside of the trust account (discussed below). Trust Account Upon the closing of the Initial Public Offering, $276 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering, including the proceeds of the Private Placement Warrants, was held in a trust account (the “Trust Account”), located in the United States at J.P. Morgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated Initial Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete an initial Business Combination with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the amount of any deferred underwriting discount held in the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). The Company will provide its holders of its Class A ordinary shares (the “Public Shareholders”), par value $0.0001, sold in the Initial Public Offering (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro-rata The per-share amount Notwithstanding the foregoing, the Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, officers and directors (the “initial shareholders”) have agreed, pursuant to a written agreement with the Company, that they will not propose any amendment to the Amended and Restated Memorandum and Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering (the “Combination Period”), which is February 13, 2022, or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares upon approval of any such amendment at a per-share price, The Company will have 24 months from the closing of the Initial Public Offering to complete its initial Business Combination. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, Liquidation The initial shareholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders or members of the Company’s management team acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to its deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern As of December 31, 2020, the Company had $913,755 in working capital and $981,606 of cash outside the Trust Account available for working capital needs. All cash and securities held in the Trust Account are generally unavailable for the Company’s use, prior to an initial Business Combination, and are restricted for use either in a Business Combination or to redeem ordinary shares. As of December 31, 2020, none of the amount in the Trust Account was available to be withdrawn as described above. Through December 31, 2020, the Company’s liquidity needs were satisfied through receipt of $25,000 from the sale of the Founder Shares, advances from the Sponsor in an aggregate amount of $300,000 which were repaid upon the Initial Public Offering (as described in Note 5) and the funds held outside the Trust Account and private placement (as described in Note 4 and 5). The Company anticipates that the $981,606 outside of the Trust Account as of December 31, 2020, will be sufficient to allow the Company to operate for at least the next 12 months, assuming that a Business Combination is not consummated during that time. Until consummation of its Business Combination, the Company will be using the funds not held in the Trust Account, and any additional Working Capital Loans (as defined below) from the Initial Shareholders, the Company’s officers and directors, or their respective affiliates (which is described in Note 5), for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the Business Combination. The Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the Company’s estimates of the costs of undertaking in-depth due

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	12 Months Ended
	Dec. 31, 2020
Prior Period Adjustment [Abstract]
Restatement of Previously Issued Financial Statements	Note 2—Restatement of Previously Issued Financial Statements On April 12, 2021, the Staff of the Securities and Exchange Commission together issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Statement”). Specifically, the SEC Statement focused on certain settlement terms and provisions related to certain tender offers following a Business Combination, which terms are similar to those contained in the warrant agreement, dated as of September 8, 2020, between the Company and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agreement”). As a result of the SEC Statement, the Company reevaluated the accounting treatment of (i) the 13,800,000 Public Warrants, (ii) the 7,520,000 Private Warrants, (See Note 4 and Note 5). The Company previously accounted for all Warrants as components of equity. In further consideration of the guidance in Accounting Standards Codification (“ASC”) 815-40, Derivatives IPO) and at each reporting The Company’s management and the audit committee of the Company’s Board of Directors concluded that it is appropriate to restate the Company’s previously issued audited financial statements as of December 31, 2020 and for the period from September 9, 2019 (inception) through December 31, 2020, as previously reported in its Form 10-K. The ASC 815-40 are The following tables summarize the effect of the restatement on each financial statement line item as of the dates, and for the period, indicated: As Previously Adjustment As Restated Balance Sheet at February 13, 2020 Warrant Liability $ — $ 28,806,800 $ 28,806,800 Class A ordinary shares subject to possible redemption 262,859,036 (28,806,800 ) 234,052,236 Class A ordinary shares 131 288 419 Additional paid-in capital 5,024,174 3,973,967 8,998,141 Accumulated deficit $ (24,990 ) $ (3,974,255 ) $ (3,999,245 ) As Previously Adjustment As Restated Selected Balance Sheet Items at March 31 Warrant Liability $ — $ 17,557,600 $ 17,557,600 Class A ordinary shares subject to possible redemption, 264,535,214 (17,557,596 ) 246,977,618 Class A ordinary shares 115 175 290 Additional paid-in capital 3,308,081 (7,272,469 ) (3,964,388 ) Accumulated deficit $ 1,691,119 $ 7,272,290 $ 8,963,409 Selected Condensed Statement of Operations Items for Three Months Ended March 31, 2020 Warrants issuance costs $ — (1,044,453 ) (1,044,453 ) Excess of the fair value of private placement warrants over the cash received — (2,932,800 ) (2,932,800 ) Unrealized loss on change in fair value of warrants — 11,249,200 11,249,200 Net income (loss) $ 1,714,085 $ 7,272,290 $ 8,986,375 Weighted average shares outstanding of Class B ordinary shares, basic and diluted 6,900,000 (425,275 ) 6,474,725 Basic and diluted net loss per ordinary share, Class B $ (0.01 ) 1.13 1.12 As Previously Adjustment As Restated Selected Condensed Statement of Cash Flow Items for Three Months Ended March 31, 2020 Cash Flows from Operating Activities: Net income (loss) $ 1,714,085 $ 7,272,290 $ 8,986,375 Excess of the fair value of private placement warrants over the cash received — 2,932,800 2,932,800 Warrant issuance costs — 1,044,110 1,044,110 Unrealized gain/loss on fair value changes of warrants $ — $ (11,249,200 ) $ (11,249,200 ) As Previously Adjustment As Restated Selected Balance Sheet Items at June 30, 2020 Warrant Liability $ — $ 16,014,800 $ 16,014,800 Class A ordinary shares subject to possible redemption, 264,434,096 (16,014,800 ) 248,419,296 Class A ordinary shares 116 160 276 Additional paid-in capital 3,404,038 (8,814,907 ) (5,410,869 ) Accumulated deficit $ 1,595,157 $ 8,814,747 $ 10,409,904 Selected Condensed Statement of Operations Items for Six Months Ended June 30, 2020 Warrants issuance costs $ — (1,044,453 ) (1,044,453 ) Excess of the fair value of private placement warrants over the cash received — (2,932,800 ) (2,932,800 ) Unrealized loss on change in fair value of warrants — 12,792,000 12,792,000 Net income (loss) $ 1,618,123 $ 8,814,747 $ 10,432,870 Weighted average shares outstanding of Class B ordinary shares, basic and diluted 6,900,000 (212,637 ) 6,687,363 Basic and diluted net loss per ordinary share, Class B $ (0.03 ) 1.32 1.29 Selected Condensed Statement of Cash Flow Items for Six Months Ended June 30, 2020 Cash Flows from Operating Activities: Net income (loss) $ 1,618,123 $ 8,814,747 $ 10,432,870 Excess of the fair value of private placement warrants over the cash received — 2,932,800 2,932,800 Warrant issuance costs — 1,044,453 1,044,453 Unrealized gain (loss) on fair value changes of warrants $ — $ (12,792,000 ) $ (12,792,000 ) As Previously Adjustment As Restated Selected Balance Sheet Items at September 30, 2020 Warrant Liability $ — $ 27,101,200 $ 27,101,200 Class A ordinary shares subject to possible redemption, 264,272,806 (27,101,199 ) 237,171,607 Class A ordinary shares 118 270 388 Additional paid-in capital 3,565,326 2,271,382 5,836,708 Accumulated deficit $ 1,433,868 $ (2,271,653 ) $ (837,785 ) Selected Condensed Statement of Operations Items for Nine Months Ended September 30, 2020 Warrants issuance costs $ — (1,044,453 ) (1,044,453 ) Excess of the fair value of private placement warrants over the cash received — (2,932,800 ) (2,932,800 ) Unrealized loss on change in fair value of warrants — 1,705,600 1,705,600 Net income (loss) $ 1,456,834 $ (2,271,653 ) $ (814,819 ) Weighted average shares outstanding of Class B ordinary shares, basic and diluted 6,900,000 (141,241 ) 6,758,759 Basic and diluted net loss per ordinary share, Class B $ (0.06 ) (0.33 ) (0.39 ) Selected Condensed Statement of Cash Flows Items for Nine Months Ended September 30, 2020 Cash Flows from Operating Activities: Net income (loss) $ 1,456,834 $ (2,271,653 ) $ (814,819 ) Excess of the fair value of private placement warrants over the cash received — 2,932,800 2,932,800 Warrant issuance costs — 1,044,453 1,044,453 Unrealized gain (loss) on fair value changes of warrants $ — $ (1,705,600 ) $ (1,705,600 )

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2—Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements of the Company are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC, and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for the fair presentation of the financial position as of June 30, 2021 and the results of operations and cash flows for the period presented and should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on February 12, 2020, the Company’s Cu r p on Form 8-K, as filed 10-K/A, . Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt-out non-emerging opt-out opt-out growth Use of Estimates The preparation of these financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021. Investments Held in Trust Account At June 30, 2021 and December 31, 2021 Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on Investments Held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Offering Costs The Company complies with the requirements of FASB ASC 340-10-S99-1 Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “ Distinguishing Liabilities from Equity June 30, 2021 Net Income (loss) per Ordinary Share The Company’s condensed statement of operations includes a presentation of income (loss) per share for common shares subject to possible redemption in a manner similar to the two-class for the six months ended June 30, 2021 and June 30, 2020 Net income per ordinary share, basic and diluted for Class B non-redeemable ordinary non-redeemable non-redeemable Income Taxes The Company accounts for income taxes in accordance with FASB ASC 740, “Income Taxes” (“ASC 740”). ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2021 and December 31, 2020. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2021 and December 31, 2020. The Company is currently not aware of any issues that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value , other than the derivative warrant liability. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers includ e: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The Company’s private warrants Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are recorded at fair value on the grant date and re-valued at or non-current based not net-cash settlement FASB ASC 470-20, Debt Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.	Note 3—Summary of Significant Accounting Policies Basis of Presentation The accompanying financial statements of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt-out of to non-emerging growth to opt-out is to opt-out of Use of Estimates The preparation of these financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three Investments Held in Trust Account At December 31, 2020, the assets held in the Trust Account were held in money market funds. The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, investments in money market funds that invest in U.S. government securities, cash, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on Investments Held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Offering Costs The Company complies with the requirements of FASB ASC 340-10-S99-1 and Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2020, 22,747,963 Class A ordinary shares subject to possible redemption were presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Net Income (loss) per Ordinary Share Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. The Company has not considered the effect of warrants sold in the Initial Public Offering and private placement to purchase 7,520,000 of Class A ordinary shares in the calculation of diluted income (loss) per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The Company complies with accounting and disclosure requirements ASC Topic 260, “Earnings Per Share.” The Company’s statements of operations include a presentation of income (loss) per share for ordinary shares subject to possible redemption in a manner similar to the two-class Class B non-redeemable ordinary Class B non-redeemable ordinary Class B non-redeemable ordinary Net loss per share for the period from September 9, 2019 (inception) through December 31, 2019 is computed by dividing net loss by the weighted average number of Class B ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 900,000 ordinary shares that are subject to forfeiture by the Company if the over-allotment option is not exercised by the underwriters (see Note 8). The Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the year For the Redeemable Class A ordinary shares Numerator: Earnings allocable to Redeemable Class A ordinary shares Interest income and realized gain from sale of treasury securities $ 1,845,877 $ — Redeemable net earnings $ 1,845,877 $ — Denominator: Weighted average redeemable Class A ordinary shares Redeemable Class A ordinary shares, basic and diluted 27,600,000 — Earnings/basic and diluted redeemable Class A ordinary shares $ 0.07 $ — Non-redeemable Class B Numerator: Net income minus redeemable net earnings Net income (loss) $ (10,506,796 ) $ (22,966 ) Redeemable net earnings 1,845,877 — Non-redeemable net $ (12,352,673 ) $ (22,966 ) Denominator: weighted average non-redeemable Class B Non-redeemable Class B 6,794,262 6,000,000 Loss/ Basic and diluted non-redeemable $ (1.82 ) $ (0.00 ) Income Taxes The Company accounts for income taxes in accordance with FASB ASC 740, “Income Taxes” (“ASC 740”). ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2020 and 2019. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of December 31, 2020 and 2019. The Company is currently not aware of any issues that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limits of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The fair value of investments held in the Trust Account is determined using quoted prices in active markets. The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature. The Company’s warrant liability is based on a valuation model utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. Significant deviations from these estimates and inputs could result in a material change in fair value. The fair value of the warrant liability is classified as level 1 for the public warrants and level 3 for the private warrants. See Note 7 for additional information on assets and liabilities measured at fair value. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are recorded at fair value on the grant date and re-valued at or non-current based not net-cash settlement FASB ASC 470-20, Debt Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material impact on the Company’s financial statements. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic .

Initial Public Offering

Initial Public Offering	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Text Block [Abstract]
Initial Public Offering	Note 3—Initial Public Offering On February 13, 2020, the Company sold 27,600,000 Units at a price of $10.00 per Unit, including 3,600,000 Units issued pursuant to the exercise in full of the underwriters’ over-allotment option. Each Unit consists of one Class A ordinary share, par value $0.0001 one-half The Company paid an underwriting discount at the closing of the Initial Public Offering of $5.52 million. An additional fee of $9.66 million was deferred and initial Business Combination. The Warrants The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement). If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. The Company is not registering the Class A ordinary shares issuable upon exercise of the warrants at this time. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its best efforts to file with the SEC and have an effective registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects register The warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. If (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares held by the initial shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination, and (z) the volume weighted average trading price of the Class A ordinary shares during the 10 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price of the Warrants will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that, so long as they are held by the Sponsor or its permitted transferees, the Private Placement Warrants (i) will not be redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants. The Company may call the Public Warrants for redemption (except with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption; and • if, and only if, the last reported closing price of the Class A ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a 30-trading If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. Additionally, in no event will the Company be required to net cash settle any Warrants. If the Company is unable to complete the initial Business Combination within the combination period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.	Note 4—Initial Public Offering On February 13, 2020, the Company sold 27,600,000 Units at a price of $10.00 per Unit, including 3,600,000 Units issued pursuant to the exercise in full of the underwriters’ over-allotment option. Each Unit consists of one Class A ordinary share, par value $0.0001 per share and one-half of The Company paid an underwriting discount at the closing of the Initial Public Offering of $5.52 million. An additional fee of $9.66 million was deferred and will become payable upon the Company’s completion of an initial Business Combination. The deferred portion of the discount will become payable to the underwriters from the amounts held in the Trust Account solely in the event the Company completes its initial Business Combination. Warrants As of December 31, 2020, there were 21,320,000 warrants outstanding, including 13,800,000 public warrants and 7,520,000 private warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b)12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement). If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. The Company is not registering the Class A ordinary shares issuable upon exercise of the warrants at this time. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its best efforts to file with the SEC and have an effective registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. If (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares held by the initial shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination, and (z) the volume weighted average trading price of the Class A ordinary shares during the 10 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price of the Warrants will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that, so long as they are held by the Sponsor or its permitted transferees, the Private Placement Warrants (i) will not be redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants. The Company may call the Public Warrants for redemption (except with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption; and • if, and only if, the last reported closing price of the Class A ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. Additionally, in no event will the Company be required to net cash settle any Warrants. If the Company is unable to complete the initial Business Combination within the combination period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Related Party Transactions

Related Party Transactions	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	Note 4—Related Party Transactions Founder Shares On November , , the Sponsor paid $ , or approximately $ per share, to cover certain offering costs in consideration for Class B ordinary shares, par value $ (the “Founder Shares”). Effective December , , the Sponsor transferred Founder Shares to Henri Arif, the Company’s independent director, for a purchase price of $ (the same per-share price initially paid by the Sponsor), resulting in the Sponsor holding Founder Shares. On February , , the Company effected a share capitalization of Class B ordinary shares and as a result, Mr. Arif now holds Founder Shares. On February , , the Sponsor appointed Mark B. Segall as an independent director and transferred Founder Shares to Mr. Segall, resulting in the Sponsor holding Founder Shares. As of June 30, 2021 June 30, 2021 , . The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares and any Class A ordinary share issuable upon conversion thereof until the earlier to occur of: (i) one year after the completion of the initial Business Combination, or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the “lock-up”). if (1) the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations days after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination which results in the Company’s shareholders having the right to exchang e released from the lock-up. Private Placement Warrants Concurrently with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 7,520,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant. Each warrant is exercisable to purchase one Class A ordinary share at $11.50 per share. The proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. On March 30, 2020, the Sponsor transferred 940,000 Private Placement Warrants to Mr. Arif. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Related Party Advances As of June 30, 2021 The amounts were unpaid reimbursements for the operating expenses, administrative support expenses (as described below—Administrative Support Agreement), merger related expenses and deferred offering costs paid by the related parties on behalf of the Company. Sponsor Loan On December 9, 2019, the Sponsor loaned the Company $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest Working Capital Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company will repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into private placement warrants at a price of $1.00 per warrant. As of June 30, 2021 Administrative Support Agreement Commencing on the date of the final prospectus, the Company has agreed to pay the Sponsor a total of $10,000 per month for office space, utilities, secretarial and administrative support services. For the three and six June 30, 2021 arrangement, respectively. For the three and six months ended June 30, 2020, the Company incurred $45,714 and $15,714 of administrative services under this arrangement, respectively. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees.	Note 5—Related Party Transactions Founder Shares On November 14, 2019, the Sponsor paid $25,000, or approximately $0.004 per share, to cover certain offering costs in consideration for 5,750,000 Class B ordinary shares, par value $0.0001 (the “Founder Shares”). Effective December 10, 2019, the Sponsor transferred 718,750 Founder Shares to Henri Arif, the Company’s independent director, for a purchase price of $3,125 (the same per-share price As of December 31, 2020, the Sponsor holds 6,015,500 Founder Shares. The initial shareholders had agreed to forfeit up to 900,000 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters. As of December 31, 2020, the underwriter had exercised its over-allotment option in full, hence, these Founder Shares are no longer subject to forfeiture. The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares and any Class A ordinary share issuable upon conversion thereof until the earlier to occur of: (i) one year after the completion of the initial Business Combination, or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; except to certain permitted transferees and under certain circumstances (the “lock-up”). Notwithstanding any 30-trading day the lock-up. Private Placement Warrants Concurrently with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 7,520,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant. Each warrant is exercisable to purchase one Class A ordinary share at $11.50 per share. The proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. On March 30, 2020, the Sponsor transferred 940,000 Private Placement Warrants to Mr. Arif. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Related Party Advances As of December 31, 2020 and 2019, the amount due to related parties was $55,931 and $85,851, respectively. The amounts were unpaid reimbursements for the operating expenses, administrative support expenses (as described below—Administrative Services Agreement), and deferred offering costs paid by the related parties on behalf of the Company. Sponsor Loan On December 9, 2019, the Sponsor loaned the Company $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest bearing Working Capital Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company will repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into Private Placement Warrants at a price of $1.00 per warrant. As of December 31, 2020 and 2019, the Company had no Working Capital Loans outstanding. Administrative Services Agreement Commencing on February 13, 2020, the Company has agreed to pay the Sponsor a total of $10,000 per month for office space, utilities, secretarial and administrative support services. For the year ended December 31, 2020, the Company incurred $105,862 in such administrative services under this arrangement. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees.

Commitments & Contingencies

Commitments & Contingencies	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments & Contingencies	Note 5—Commitments & Contingencies Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 Registration Rights The holders of Founder Shares, Private Placement Warrants, and securities that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights pursuant to a registration rights agreement dated as of February 10, 2020. These holders are entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up Underwriting Agreement The underwriters were paid a cash underwriting discount of $ , or $ per Unit of the gross proceeds of the initial Units (inclusive of unit over-allotment option) sold in the Initial Public Offering, in the aggregate. In addition, the underwriters are entitled to a deferred fee of (i) $ per Unit of the gross proceeds of the initial Units sold in the Initial Public Offering, or $ , and (ii) $ per Unit of the gross proceeds from the Units sold pursuant to the over-allotment option, or $ , aggregating to a deferred fee of $ . The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.	Note 6—Commitments & Contingencies Registration Rights The holders of Founder Shares, Private Placement Warrants, and securities that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights pursuant to a registration rights agreement dated as of February 10, 2020. These holders are entitled to certain demand and “piggyback” registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters were paid a cash underwriting discount of $5,520,000, or $0.20 per Unit of the gross proceeds of the initial 27,600,000 Units (inclusive of 3,600,000 Unit over-allotment option) sold in the Initial Public Offering, in the aggregate. In addition, the underwriters are entitled to a deferred fee of (i) $0.35 per Unit of the gross proceeds of the initial 24,000,000 Units sold in the Initial Public Offering, or $8,400,000, and (ii) $0.35 per Unit of the gross proceeds from the 3,600,000 Units sold pursuant to the over-allotment option, or $1,260,000, aggregating to a deferred fee of $9,660,000. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Recurring Fair Value Measuremen

Recurring Fair Value Measurements	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Assets Held-in-trust [Abstract]
Recurring Fair Value Measurements	Note 6—Recurring Fair Value Measurements As of June 30, 2021, investment securities in the Company’s Trust Account consisted of a treasury securities fund in the amount of $ 277,859,656 which was held as money market funds. The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of June 30, 2021 , Carrying Quoted Prices Significant Significant Assets: Investments held in Trust Account—Money Market Fund $ 277,859,656 $ 277,859,656 $ — $ — $ 277,859,656 $ 277,859,656 $ — $ — Liabilities: Warrant Liabilities—Public Warrants $ 14,628,000 $ 14,628,000 — — Warrant Liabilities—Private Warrants $ 8,347,200 — — $ 8,347,200 $ 22,975,200 $ 14,628,000 — $ 8,347,200 The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of December 31, 2020, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. Carrying Quoted Prices Significant Significant Assets: Investments held in Trust Account—Money Market Fund $ 277,845,876 $ 277,845,876 $ — $ — $ 277,845,876 $ 277,845,876 $ — $ — Liabilities: Warrant Liabilities—Public Warrants $ 23,460,000 $ 23,460,000 — — Warrant Liabilities—Private Warrants $ 13,160,000 — — $ 13,160,000 $ 36,620,000 $ 23,460,000 — $ 13,160,000 The Warrants were accounted for as liabilities in accordance with ASC 815-40 The Private Warrants are considered to be a Level 3 fair value measurements due to the use of unobservable inputs. The Black Scholes Option Pricing Model’s primary unobservable input utilized in determining the fair value of the Private Warrants is the expected volatility of the ordinary shares. The expected volatility as of the IPO date was derived from the post-merger announced publicly traded warrants for comparable SPAC companies as of the valuation date. A Monte Carlo Simulation Method was used in estimating the fair value of the public warrants for periods where no observable traded price was available, using the same expected volatility as was used in measuring the fair value of the Private Warrants. For periods subsequent to the detachment of the warrants from the Units, including June 30, 2021 and December 31, 2020, the closing price of the public warrants was used as the fair value as of each relevant date. The key inputs into the Black Scholes Option Pricing Model for the Private Warrants were as follows at each of the following balance sheet dates: Input December 31, 2020 June Risk-free interest rate 0.47 % 0.99 % Expected term (years) 5.00 5.00 Expected volatility 22.0 % 17.0 % Dividend yield 0.0 % 0.0 % Exercise price $ 11.50 $ 11.50 Asset Price $ 10.48 $ 9.91 The following table presents the changes in the fair value of warrant liabilities: Private Public Warrant Fair value as of December 31, 2020 $ 13,160,000 $ 23,460,000 $ 36,620,000 Change in valuation inputs or other assumptions (4,812,800 ) (8,832,000 ) (12,428,400 ) Fair value as of June 30, 2021 $ 8,347,200 $ 14,628,000 $ 22,975,200 Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period. There were no transfers between levels for the six months ended June 30, 2021.	Note 7—Recurring Fair Value Measurements The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs At December 31, 2020, assets held in the Trust Account were comprised of $277,845,876 in money market funds. Through December 31, 2020, the Company did no Carrying Value Quoted Prices Significant Significant Assets: Investments held in Trust Account—Money Market Fund $ 277,845,876 $ 277,845,876 $ — $ — Liabilities: Warrant Liabilities—Public Warrants $ 23,460,000 $ 23,460,000 — — Warrant Liabilities—Private Warrants $ 13,160,000 — — $ 13,160,000 $ 36,620,000 $ 23,460,000 — $ 13,160,000 The Warrants were accounted for as liabilities in accordance with ASC 815-40 and The Private Warrants were initially valued using a Black Scholes Option Pricing Model. The Private Warrants are considered to be a Level 3 fair value measurements due to the use of unobservable inputs. The Black Scholes Option Pricing Model’s primary unobservable input utilized in determining the fair value of the Private Warrants is the expected volatility of the ordinary shares. The expected volatility as of the IPO date was derived from the post-merger announced publicly traded warrants for comparable SPAC companies as of the valuation date. A Monte Carlo Simulation Method was used in estimating the fair value of the public warrants for periods where no observable traded price was available, using the same expected volatility as was used in measuring the fair value of the Private Warrants. For periods subsequent to the detachment of the warrants from the Units, including December 31, 2020, the closing price of the public warrants was used as the fair value as of each relevant date. The key inputs into the Black Scholes Option Pricing Model for the Private Warrants were as follows at initial measurement and each of the following balance sheet date: Input February 13, 2020 March 31, June 30, September 30, December 31, Risk-free interest rate 1.48 % 0.5 % 0.37 % 0.35 % 0.47 % Expected term (years) 5.00 5.00 5.00 5.00 5.00 Expected volatility 22.0 % 17 % 15.0 % 21.0 % 22 % Dividend yield 0.0 % 0.0 % 0.0 % 0.0 % 0.0 % Exercise price $ 11.5 $ 11.5 $ 11.50 $ 11.50 $ 11.50 Asset Price $ 9.48 $ 9.46 $ 9.82 $ 9.83 $ 10.48 The key inputs into the Monte Carlo Simulation Method for the Public Warrants were as follows at initial measurement and March 31, 2021: Input February 13, 2020 March 31, Risk-free interest rate 1.48 % 0.5 % Expected term (years) 5.00 5.00 Expected volatility 22.0 % 17.0 % Dividend yield 0.0 % 0.0 % Exercise price $ 11.5 $ 11.5 Asset Price $ 9.48 $ 9.46 The following table presents the changes in the fair value of warrant liabilities: Private Public Warrant Initial measurement on February 13, 2020 $ 10,452,800 $ 18,354,000 $ 28,806,800 Change in valuation inputs or other assumptions 2,707,200 5,106,000 7,813,200 Fair value as of December 31, 2020 $ 13,160,000 $ 23,460,000 $ 36,620,000 Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period. There were no transfers between levels for the period from September 9, 2019 (inception) through December 31, 2020 other than the transfer of the Public Warrants from Level 3 to Level 1.

Shareholders' Equity

Shareholders' Equity	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Federal Home Loan Banks [Abstract]
Shareholders' Equity	Note 7—Shareholders’ Equity Class A Ordinary Shares— Class B Ordinary Shares Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares have the right to vote on the election of the Company’s directors prior to the initial Business Combination. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination on a one-for-one basis (as adjusted). 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by Public Shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one Preferred Shares June 30, 2021	Note 8—Shareholders’ Equity Class A Ordinary Shares— Class B Ordinary Shares Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares have the right to appoint directors in any election held prior to or in connection with the completion of the initial Business Combination. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination on a one-for-one basis than one-for-one basis. Preferred Shares

Subsequent Events

Subsequent Events	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 8—Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were available to be issued and has concluded that all such events that would require adjustment or disclosure have been recognized or disclosed.	Note 9—Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were available to be issued and has concluded that other than the events disclosed below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. On February 10, 2021, the Company appointed Mark B. Segall as an independent director and CITIC Capital Acquisition LLC, the Company’s Sponsor, transferred 13,000 Founder Shares to Mr. Segall.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements of the Company are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC, and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for the fair presentation of the financial position as of June 30, 2021 and the results of operations and cash flows for the period presented and should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on February 12, 2020, the Company’s Cu r p on Form 8-K, as filed 10-K/A, .	Basis of Presentation The accompanying financial statements of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt-out non-emerging opt-out opt-out growth	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt-out of to non-emerging growth to opt-out is to opt-out of
Use of Estimates	Use of Estimates The preparation of these financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.	Use of Estimates The preparation of these financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021.	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three
Investments Held in Trust Account	Investments Held in Trust Account At June 30, 2021 and December 31, 2021 Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on Investments Held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.	Investments Held in Trust Account At December 31, 2020, the assets held in the Trust Account were held in money market funds. The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, investments in money market funds that invest in U.S. government securities, cash, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on Investments Held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Offering Costs	Offering Costs The Company complies with the requirements of FASB ASC 340-10-S99-1	Offering Costs The Company complies with the requirements of FASB ASC 340-10-S99-1 and
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “ Distinguishing Liabilities from Equity June 30, 2021	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2020, 22,747,963 Class A ordinary shares subject to possible redemption were presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
Net Income (loss) per Ordinary Share	Net Income (loss) per Ordinary Share The Company’s condensed statement of operations includes a presentation of income (loss) per share for common shares subject to possible redemption in a manner similar to the two-class for the six months ended June 30, 2021 and June 30, 2020 Net income per ordinary share, basic and diluted for Class B non-redeemable ordinary non-redeemable non-redeemable	Net Income (loss) per Ordinary Share Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. The Company has not considered the effect of warrants sold in the Initial Public Offering and private placement to purchase 7,520,000 of Class A ordinary shares in the calculation of diluted income (loss) per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The Company complies with accounting and disclosure requirements ASC Topic 260, “Earnings Per Share.” The Company’s statements of operations include a presentation of income (loss) per share for ordinary shares subject to possible redemption in a manner similar to the two-class Class B non-redeemable ordinary Class B non-redeemable ordinary Class B non-redeemable ordinary Net loss per share for the period from September 9, 2019 (inception) through December 31, 2019 is computed by dividing net loss by the weighted average number of Class B ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 900,000 ordinary shares that are subject to forfeiture by the Company if the over-allotment option is not exercised by the underwriters (see Note 8). The Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the year For the Redeemable Class A ordinary shares Numerator: Earnings allocable to Redeemable Class A ordinary shares Interest income and realized gain from sale of treasury securities $ 1,845,877 $ — Redeemable net earnings $ 1,845,877 $ — Denominator: Weighted average redeemable Class A ordinary shares Redeemable Class A ordinary shares, basic and diluted 27,600,000 — Earnings/basic and diluted redeemable Class A ordinary shares $ 0.07 $ — Non-redeemable Class B Numerator: Net income minus redeemable net earnings Net income (loss) $ (10,506,796 ) $ (22,966 ) Redeemable net earnings 1,845,877 — Non-redeemable net $ (12,352,673 ) $ (22,966 ) Denominator: weighted average non-redeemable Class B Non-redeemable Class B 6,794,262 6,000,000 Loss/ Basic and diluted non-redeemable $ (1.82 ) $ (0.00 )
Income Taxes	Income Taxes The Company accounts for income taxes in accordance with FASB ASC 740, “Income Taxes” (“ASC 740”). ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2021 and December 31, 2020. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2021 and December 31, 2020. The Company is currently not aware of any issues that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.	Income Taxes The Company accounts for income taxes in accordance with FASB ASC 740, “Income Taxes” (“ASC 740”). ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2020 and 2019. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of December 31, 2020 and 2019. The Company is currently not aware of any issues that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limits of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value , other than the derivative warrant liability.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers includ e: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The Company’s private warrants	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The fair value of investments held in the Trust Account is determined using quoted prices in active markets. The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature. The Company’s warrant liability is based on a valuation model utilizing management judgment and pricing inputs from observable and unobservable markets with less volume and transaction frequency than active markets. Significant deviations from these estimates and inputs could result in a material change in fair value. The fair value of the warrant liability is classified as level 1 for the public warrants and level 3 for the private warrants. See Note 7 for additional information on assets and liabilities measured at fair value.
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are recorded at fair value on the grant date and re-valued at or non-current based not net-cash settlement FASB ASC 470-20, Debt	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. Derivative instruments are recorded at fair value on the grant date and re-valued at or non-current based not net-cash settlement FASB ASC 470-20, Debt
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.	Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material impact on the Company’s financial statements.
Risks and Uncertainties		Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic .

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	12 Months Ended
	Dec. 31, 2020
Prior Period Adjustment [Abstract]
Summary of Restatement of Financial Statements	The following tables summarize the effect of the restatement on each financial statement line item as of the dates, and for the period, indicated: As Previously Adjustment As Restated Balance Sheet at February 13, 2020 Warrant Liability $ — $ 28,806,800 $ 28,806,800 Class A ordinary shares subject to possible redemption 262,859,036 (28,806,800 ) 234,052,236 Class A ordinary shares 131 288 419 Additional paid-in capital 5,024,174 3,973,967 8,998,141 Accumulated deficit $ (24,990 ) $ (3,974,255 ) $ (3,999,245 ) As Previously Adjustment As Restated Selected Balance Sheet Items at March 31 Warrant Liability $ — $ 17,557,600 $ 17,557,600 Class A ordinary shares subject to possible redemption, 264,535,214 (17,557,596 ) 246,977,618 Class A ordinary shares 115 175 290 Additional paid-in capital 3,308,081 (7,272,469 ) (3,964,388 ) Accumulated deficit $ 1,691,119 $ 7,272,290 $ 8,963,409 Selected Condensed Statement of Operations Items for Three Months Ended March 31, 2020 Warrants issuance costs $ — (1,044,453 ) (1,044,453 ) Excess of the fair value of private placement warrants over the cash received — (2,932,800 ) (2,932,800 ) Unrealized loss on change in fair value of warrants — 11,249,200 11,249,200 Net income (loss) $ 1,714,085 $ 7,272,290 $ 8,986,375 Weighted average shares outstanding of Class B ordinary shares, basic and diluted 6,900,000 (425,275 ) 6,474,725 Basic and diluted net loss per ordinary share, Class B $ (0.01 ) 1.13 1.12 As Previously Adjustment As Restated Selected Condensed Statement of Cash Flow Items for Three Months Ended March 31, 2020 Cash Flows from Operating Activities: Net income (loss) $ 1,714,085 $ 7,272,290 $ 8,986,375 Excess of the fair value of private placement warrants over the cash received — 2,932,800 2,932,800 Warrant issuance costs — 1,044,110 1,044,110 Unrealized gain/loss on fair value changes of warrants $ — $ (11,249,200 ) $ (11,249,200 ) As Previously Adjustment As Restated Selected Balance Sheet Items at June 30, 2020 Warrant Liability $ — $ 16,014,800 $ 16,014,800 Class A ordinary shares subject to possible redemption, 264,434,096 (16,014,800 ) 248,419,296 Class A ordinary shares 116 160 276 Additional paid-in capital 3,404,038 (8,814,907 ) (5,410,869 ) Accumulated deficit $ 1,595,157 $ 8,814,747 $ 10,409,904 Selected Condensed Statement of Operations Items for Six Months Ended June 30, 2020 Warrants issuance costs $ — (1,044,453 ) (1,044,453 ) Excess of the fair value of private placement warrants over the cash received — (2,932,800 ) (2,932,800 ) Unrealized loss on change in fair value of warrants — 12,792,000 12,792,000 Net income (loss) $ 1,618,123 $ 8,814,747 $ 10,432,870 Weighted average shares outstanding of Class B ordinary shares, basic and diluted 6,900,000 (212,637 ) 6,687,363 Basic and diluted net loss per ordinary share, Class B $ (0.03 ) 1.32 1.29 Selected Condensed Statement of Cash Flow Items for Six Months Ended June 30, 2020 Cash Flows from Operating Activities: Net income (loss) $ 1,618,123 $ 8,814,747 $ 10,432,870 Excess of the fair value of private placement warrants over the cash received — 2,932,800 2,932,800 Warrant issuance costs — 1,044,453 1,044,453 Unrealized gain (loss) on fair value changes of warrants $ — $ (12,792,000 ) $ (12,792,000 ) As Previously Adjustment As Restated Selected Balance Sheet Items at September 30, 2020 Warrant Liability $ — $ 27,101,200 $ 27,101,200 Class A ordinary shares subject to possible redemption, 264,272,806 (27,101,199 ) 237,171,607 Class A ordinary shares 118 270 388 Additional paid-in capital 3,565,326 2,271,382 5,836,708 Accumulated deficit $ 1,433,868 $ (2,271,653 ) $ (837,785 ) Selected Condensed Statement of Operations Items for Nine Months Ended September 30, 2020 Warrants issuance costs $ — (1,044,453 ) (1,044,453 ) Excess of the fair value of private placement warrants over the cash received — (2,932,800 ) (2,932,800 ) Unrealized loss on change in fair value of warrants — 1,705,600 1,705,600 Net income (loss) $ 1,456,834 $ (2,271,653 ) $ (814,819 ) Weighted average shares outstanding of Class B ordinary shares, basic and diluted 6,900,000 (141,241 ) 6,758,759 Basic and diluted net loss per ordinary share, Class B $ (0.06 ) (0.33 ) (0.39 ) Selected Condensed Statement of Cash Flows Items for Nine Months Ended September 30, 2020 Cash Flows from Operating Activities: Net income (loss) $ 1,456,834 $ (2,271,653 ) $ (814,819 ) Excess of the fair value of private placement warrants over the cash received — 2,932,800 2,932,800 Warrant issuance costs — 1,044,453 1,044,453 Unrealized gain (loss) on fair value changes of warrants $ — $ (1,705,600 ) $ (1,705,600 )

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2020
Earnings Per Share [Abstract]
Summary of basic and diluted net income (loss) per ordinary share	The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): For the year For the Redeemable Class A ordinary shares Numerator: Earnings allocable to Redeemable Class A ordinary shares Interest income and realized gain from sale of treasury securities $ 1,845,877 $ — Redeemable net earnings $ 1,845,877 $ — Denominator: Weighted average redeemable Class A ordinary shares Redeemable Class A ordinary shares, basic and diluted 27,600,000 — Earnings/basic and diluted redeemable Class A ordinary shares $ 0.07 $ — Non-redeemable Class B Numerator: Net income minus redeemable net earnings Net income (loss) $ (10,506,796 ) $ (22,966 ) Redeemable net earnings 1,845,877 — Non-redeemable net $ (12,352,673 ) $ (22,966 ) Denominator: weighted average non-redeemable Class B Non-redeemable Class B 6,794,262 6,000,000 Loss/ Basic and diluted non-redeemable $ (1.82 ) $ (0.00 )

Recurring Fair Value Measurem_2

Recurring Fair Value Measurements (Tables)	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Schedule of Recurring Fair Values Investments Quoted Price in Active Markets for identical Assets	The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of June 30, 2021 , Carrying Quoted Prices Significant Significant Assets: Investments held in Trust Account—Money Market Fund $ 277,859,656 $ 277,859,656 $ — $ — $ 277,859,656 $ 277,859,656 $ — $ — Liabilities: Warrant Liabilities—Public Warrants $ 14,628,000 $ 14,628,000 — — Warrant Liabilities—Private Warrants $ 8,347,200 — — $ 8,347,200 $ 22,975,200 $ 14,628,000 — $ 8,347,200 The following table presents information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of December 31, 2020, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. Carrying Quoted Prices Significant Significant Assets: Investments held in Trust Account—Money Market Fund $ 277,845,876 $ 277,845,876 $ — $ — $ 277,845,876 $ 277,845,876 $ — $ — Liabilities: Warrant Liabilities—Public Warrants $ 23,460,000 $ 23,460,000 — — Warrant Liabilities—Private Warrants $ 13,160,000 — — $ 13,160,000 $ 36,620,000 $ 23,460,000 — $ 13,160,000	Carrying Value Quoted Prices Significant Significant Assets: Investments held in Trust Account—Money Market Fund $ 277,845,876 $ 277,845,876 $ — $ — Liabilities: Warrant Liabilities—Public Warrants $ 23,460,000 $ 23,460,000 — — Warrant Liabilities—Private Warrants $ 13,160,000 — — $ 13,160,000 $ 36,620,000 $ 23,460,000 — $ 13,160,000
Summary of fair value measurements inputs	The key inputs into the Black Scholes Option Pricing Model for the Private Warrants were as follows at each of the following balance sheet dates: Input December 31, 2020 June Risk-free interest rate 0.47 % 0.99 % Expected term (years) 5.00 5.00 Expected volatility 22.0 % 17.0 % Dividend yield 0.0 % 0.0 % Exercise price $ 11.50 $ 11.50 Asset Price $ 10.48 $ 9.91
Summary of Change in Fair Value of Warrant Liabilities	The following table presents the changes in the fair value of warrant liabilities: Private Public Warrant Fair value as of December 31, 2020 $ 13,160,000 $ 23,460,000 $ 36,620,000 Change in valuation inputs or other assumptions (4,812,800 ) (8,832,000 ) (12,428,400 ) Fair value as of June 30, 2021 $ 8,347,200 $ 14,628,000 $ 22,975,200	The following table presents the changes in the fair value of warrant liabilities: Private Public Warrant Initial measurement on February 13, 2020 $ 10,452,800 $ 18,354,000 $ 28,806,800 Change in valuation inputs or other assumptions 2,707,200 5,106,000 7,813,200 Fair value as of December 31, 2020 $ 13,160,000 $ 23,460,000 $ 36,620,000
Private Placement Warrant [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Summary of fair value measurements inputs		The key inputs into the Black Scholes Option Pricing Model for the Private Warrants were as follows at initial measurement and each of the following balance sheet date: Input February 13, 2020 March 31, June 30, September 30, December 31, Risk-free interest rate 1.48 % 0.5 % 0.37 % 0.35 % 0.47 % Expected term (years) 5.00 5.00 5.00 5.00 5.00 Expected volatility 22.0 % 17 % 15.0 % 21.0 % 22 % Dividend yield 0.0 % 0.0 % 0.0 % 0.0 % 0.0 % Exercise price $ 11.5 $ 11.5 $ 11.50 $ 11.50 $ 11.50 Asset Price $ 9.48 $ 9.46 $ 9.82 $ 9.83 $ 10.48
Public Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Summary of fair value measurements inputs		The key inputs into the Monte Carlo Simulation Method for the Public Warrants were as follows at initial measurement and March 31, 2021: Input February 13, 2020 March 31, Risk-free interest rate 1.48 % 0.5 % Expected term (years) 5.00 5.00 Expected volatility 22.0 % 17.0 % Dividend yield 0.0 % 0.0 % Exercise price $ 11.5 $ 11.5 Asset Price $ 9.48 $ 9.46

Description of Organization a_2

Description of Organization and Business Operations - Additional information (Detail) - USD ($)	Jun. 21, 2021	Feb. 13, 2020	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Organization Business And Basis Of Presentation [Line Items]
Common stock price, per share				$ 10		$ 10
Proceeds from issuance initial public offering		$ 276,000,000		$ 276,000,000	$ 276,000,000	$ 276,000,000
Incurring offering cost		15,700,000
Payment of underwriting discount		$ 9,660,000		5,520,000		5,520,000
Cash				$ 126,622		$ 981,606	$ 300,000
Percentage of voting interests acquired				50.00%		50.00%
Business combination, net tangible assets required to proceed				$ 5,000,001		$ 5,000,001
Business Combination, maximum amount of interest to pay dissolution expenses				$ 100,000		$ 100,000
Business Combination required completion period after Initial Public Offering				24 months		24 months
Operating amount out of Trust account enough to operate for at least 12 months				$ 126,622		$ 913,755
Business Combination within in the Combination Period, possible per share value of residual assets remaining available for distribution						$ 10
Stock Issued During Period, Value, Warrants						$ 7,520,000
Exercise price per share						$ 1
Proceeds from Issuance of Warrants						$ 7.52
PIPE Investment [Member] | PIPE Subscription Agreement [Member] | Quanergy PubCo common stock [Member]
Organization Business And Basis Of Presentation [Line Items]
Issuance of Ordinary Share	4,000,000
Shares issued price per share	$ 10
Proceeds from issuance of common stock	$ 40,000,000
Quanergy Systems, Inc [Member] | Merger Agreement [Member]
Organization Business And Basis Of Presentation [Line Items]
Business combination, net tangible assets required to proceed	$ 5,000,001
Business acquisition equity interest issued or iisuable,number of shares issued	970,000,000
Share price	$ 10
Founder Shares [Member]
Organization Business And Basis Of Presentation [Line Items]
Proceed from issuance of shares				$ 25,000		$ 25,000
Number of shares issued				300,000		300,000
Minimum [Member] | Quanergy Systems, Inc [Member] | PIPE Investment [Member] | Merger Agreement [Member]
Organization Business And Basis Of Presentation [Line Items]
Threshold proceeds net of redemptions for effecting a merger	$ 175,000,000
Class A Common Stock
Organization Business And Basis Of Presentation [Line Items]
Common stock par value				$ 0.0001		$ 0.0001	$ 0.0001
Class A Common Stock | Maximum [Member]
Organization Business And Basis Of Presentation [Line Items]
Percentage of aggregate Public Shares restricted from redeem				20.00%		20.00%
IPO [Member]
Organization Business And Basis Of Presentation [Line Items]
Issuance of Ordinary Share		27,600,000
Common stock price, per share		$ 10
IPO [Member] | Over-Allotment Option [Member]
Organization Business And Basis Of Presentation [Line Items]
Issuance of Ordinary Share		3,600,000
IPO [Member] | Class A Common Stock
Organization Business And Basis Of Presentation [Line Items]
Issuance of Ordinary Share			27,600,000			27,600,000
Private Placement [Member]
Organization Business And Basis Of Presentation [Line Items]
Proceeds from issuance initial public offering		$ 7,520,000

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements - Additional Information (Detail)	Dec. 31, 2020shares
Warrants Outstanding	21,320,000
Public Warrants [Member]
Warrants Outstanding	13,800,000
Private Placement [Member]
Warrants Outstanding	7,520,000

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements - Schedule Of Condensed Balance Sheet (Detail) - USD ($)	Jun. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Feb. 13, 2020	Dec. 31, 2019
Warrant liability			$ 27,101,200	$ 16,014,800	$ 17,557,600	$ 28,806,800
Additional paid-in capital	$ 5,633,547	$ 15,528,588	5,836,708	(5,410,869)	(3,964,388)	8,998,141	$ 24,310
Accumulated deficit	(634,617)	(10,529,762)	(837,785)	10,409,904	8,963,409	(3,999,245)	$ (22,966)
Previously Reported
Warrant liability			0	0	0	0
Additional paid-in capital			3,565,326	3,404,038	3,308,081	5,024,174
Accumulated deficit			1,433,868	1,595,157	1,691,119	(24,990)
Adjustment
Warrant liability			27,101,200	16,014,800	17,557,600	28,806,800
Additional paid-in capital			2,271,382	(8,814,907)	(7,272,469)	3,973,967
Accumulated deficit			(2,271,653)	8,814,747	7,272,290	(3,974,255)
Class A Common Stock
Class A ordinary shares subject to possible redemption,	237,374,770	227,479,630	237,171,607	248,419,296	246,977,618	234,052,236
Class A ordinary shares	$ 386	$ 485	388	276	290	419
Class A Common Stock | Previously Reported
Class A ordinary shares subject to possible redemption,			264,272,806	264,434,096	264,535,214	262,859,036
Class A ordinary shares			118	116	115	131
Class A Common Stock | Adjustment
Class A ordinary shares subject to possible redemption,			(27,101,199)	(16,014,800)	(17,557,596)	(28,806,800)
Class A ordinary shares			$ 270	$ 160	$ 175	$ 288

Restatement of Previously Iss_5

Restatement of Previously Issued Financial Statements - Schedule Of Condensed Income Statement (Detail) - USD ($)	3 Months Ended				4 Months Ended	6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Jun. 30, 2021	Jun. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
Warrant issuance costs			$ (343)	$ (1,044,453)			$ (1,044,453)	$ (1,044,453)	$ (1,044,453)
Excess of the fair value of private placement warrants over the cash received				(2,932,800)			(2,932,800)	(2,932,800)	(2,932,800)
Unrealized loss on change in fair value of warrants				11,249,200			12,792,000	1,705,600
Net income (loss)	$ (1,876,059)	$ 11,771,204	$ 1,446,495	$ 8,986,375	$ (22,966)	$ 9,895,145	$ 10,432,870	$ (814,819)	$ (10,506,796)
Class B common stock
Weighted average shares outstanding of Class B ordinary shares, basic and diluted	6,900,000		6,687,363	6,474,725	6,000,000	6,900,000	6,687,363	6,758,759	6,794,262
Basic and diluted net income (loss) per ordinary share	$ (0.27)		$ 0.21	$ 1.12	$ 0	$ 1.43	$ 1.29	$ (0.39)	$ (1.82)
Previously Reported
Warrant issuance costs				$ 0			$ 0	$ 0
Excess of the fair value of private placement warrants over the cash received				0			0	0
Unrealized loss on change in fair value of warrants				0			0	0
Net income (loss)				$ 1,714,085			$ 1,618,123	$ 1,456,834
Previously Reported | Class B common stock
Weighted average shares outstanding of Class B ordinary shares, basic and diluted				6,900,000			6,900,000	6,900,000
Basic and diluted net income (loss) per ordinary share				$ (0.01)			$ (0.03)	$ (0.06)
Adjustment
Warrant issuance costs				$ (1,044,453)			$ (1,044,453)	$ (1,044,453)
Excess of the fair value of private placement warrants over the cash received				(2,932,800)			(2,932,800)	(2,932,800)
Unrealized loss on change in fair value of warrants				11,249,200			12,792,000	1,705,600
Net income (loss)				$ 7,272,290			$ 8,814,747	$ (2,271,653)
Adjustment | Class B common stock
Weighted average shares outstanding of Class B ordinary shares, basic and diluted				(425,275)			(212,637)	(141,241)
Basic and diluted net income (loss) per ordinary share				$ 1.13			$ 1.32	$ (0.33)

Restatement of Previously Iss_6

Restatement of Previously Issued Financial Statements - Schedule Of Condensed Cash Flow Statement (Detail) - USD ($)	3 Months Ended				4 Months Ended	6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Jun. 30, 2021	Jun. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
Cash Flows from Operating Activities:
Net income (loss)	$ (1,876,059)	$ 11,771,204	$ 1,446,495	$ 8,986,375	$ (22,966)	$ 9,895,145	$ 10,432,870	$ (814,819)	$ (10,506,796)
Excess of the fair value of private placement warrants over the cash received				2,932,800			2,932,800	2,932,800	2,932,800
Warrant issuance costs				1,044,110			1,044,453	1,044,453
Unrealized gain (loss) on fair value changes of warrants	$ (1,216,400)		$ (1,542,800)	(11,249,200)		$ (13,644,800)	(12,792,000)	(1,705,600)	$ 7,813,200
Previously Reported
Cash Flows from Operating Activities:
Net income (loss)				1,714,085			1,618,123	1,456,834
Excess of the fair value of private placement warrants over the cash received				0			0	0
Warrant issuance costs				0			0	0
Unrealized gain (loss) on fair value changes of warrants				0			0	0
Adjustment
Cash Flows from Operating Activities:
Net income (loss)				7,272,290			8,814,747	(2,271,653)
Excess of the fair value of private placement warrants over the cash received				2,932,800			2,932,800	2,932,800
Warrant issuance costs				1,044,110			1,044,453	1,044,453
Unrealized gain (loss) on fair value changes of warrants				$ (11,249,200)			$ (12,792,000)	$ (1,705,600)

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Summary of basic and diluted net income (loss) per ordinary share (Detail) - USD ($)	3 Months Ended				4 Months Ended	6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Jun. 30, 2021	Jun. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Interest income and realized gain from sale of treasury securities						$ 13,780	$ 474,758
Net Income (Loss)	$ (1,876,059)	$ 11,771,204	$ 1,446,495	$ 8,986,375	$ (22,966)	$ 9,895,145	$ 10,432,870	$ (814,819)	$ (10,506,796)
ClassA redeemable ordinary shares [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Interest income and realized gain from sale of treasury securities									1,845,877
Net earnings									$ 1,845,877
Redeemable Class Ordinary Shares, Basic and Diluted									27,600,000
Earnings Per Share, Basic and Diluted									$ 0.07
Non Redeemable Class B Ordinary Shares [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Interest income and realized gain from sale of treasury securities									$ 1,845,877
Net earnings					$ (22,966)				$ (12,352,673)
Redeemable Class Ordinary Shares, Basic and Diluted					6,000,000				6,794,262
Earnings Per Share, Basic and Diluted					$ 0				$ (1.82)
Net Income (Loss)					$ (22,966)				$ (10,506,796)

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	3 Months Ended			4 Months Ended	6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Jun. 30, 2021	Jun. 30, 2020	Sep. 30, 2020	Dec. 31, 2020
Offering cost charged to the shareholders' equity		$ 5,160	$ 14,656,790		$ 14,661,607			$ 14,661,607
Ordinary shares subject to possible redemption	23,737,477				23,737,477			22,747,963
Gain on sale of marketable securities						$ 1,831,868		$ 1,845,877
Unrecognized tax benefits	$ 0			$ 0	$ 0			0
Accrued interest and penalties related to unrecognized tax benefits	0			0	0			0
Federal depository insurance coverage	250,000				250,000			250,000
Interest Income and Realized Gain from Sale of Treasury Securities	$ 6,928	$ 69,247		$ 0	13,780	$ 1,831,868		1,845,877
Offering cost					$ 1,044,453			$ 1,044,453
Restricted Investments Term					185 days
Common Class A [Member]
Ordinary shares subject to possible redemption	23,737,477			0	23,737,477			22,747,963
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount								7,520,000
Weighted Average Number of Shares	27,600,000	27,600,000		0	27,600,000	27,600,000		27,600,000
Common Class B [Member]
Weighted Average Number of Shares	6,900,000	6,687,363	6,474,725	6,000,000	6,900,000	6,687,363	6,758,759	6,794,262
Common Class B [Member] | Over-Allotment Option [Member] | Minimum [Member]
Weighted Average Number of Shares				900,000

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	Feb. 13, 2020	Jun. 30, 2021	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Sale of stock price per share		$ 10	$ 10
Warrant exercise price per share			$ 1
Payment of underwriting discount	$ 9,660	$ 5,520	$ 5,520
Additional fee payable		$ 9,660	$ 9,660
Warrants expiration term		5 years	5 years
Warrant exercisable price			$ 1
Warrants upon redemption, description		the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price of the Warrants will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price
Warrants Outstanding			21,320,000
Private Placement Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Redemption price per share		$ 0.01	$ 0.01
Share issue price per shares		$ 18	$ 18
Warrants upon redemption, description		if, and only if, the last reported closing price of the Class A ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders	if, and only if, the last reported closing price of the Class A ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
Warrants Outstanding			7,520,000
Public Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant exercise price per share		$ 9.20	$ 9.20
Redemption price per share		18	18
Warrant exercisable price		9.20	$ 9.20
Warrants upon redemption, description			the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price of the Warrants will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price
Warrants Outstanding			13,800,000
Public Warrant [Member] | Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Share issue price per shares		$ 9.20	$ 9.20
Percentage of equity proceeds		60.00%	60.00%
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of stock, shares issued	27,600,000
Sale of stock price per share	$ 10
IPO [Member] | Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of stock, shares issued	3,600,000
Warrant
Subsidiary, Sale of Stock [Line Items]
Warrant exercise price per share	$ 11.50	$ 0.0001	$ 0.0001
Warrant exercisable price	$ 11.50	$ 0.0001	$ 0.0001

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)	Jun. 30, 2021	Feb. 10, 2021	Dec. 31, 2020	Feb. 13, 2020	Feb. 10, 2020	Dec. 10, 2019	Dec. 09, 2019	Nov. 14, 2019	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	Mar. 30, 2020	Dec. 31, 2019
Shares price	$ 10		$ 10						$ 10		$ 10		$ 10
Ordinary shares, issued	23,737,477		22,747,963						23,737,477		23,737,477		22,747,963
Warrant exercisable price			$ 1										$ 1
Due to related parties	$ 385,366		$ 55,931						$ 385,366		$ 385,366		$ 55,931		$ 85,851
Advance from Sponsor							$ 300,000
Repayment of Sponsor loan				$ 300,000
Stock Issued During Period, Value, New Issues													$ 0
Private Placement Warrant [Member]
Purchased to aggregate warrant											7,520,000		7,520,000
Warrant purchase price											$ 1		$ 1
Warrant exercisable price	$ 11.50		$ 11.50						$ 11.50		$ 11.50		$ 11.50
Warrant transferred to related party														940,000
Initial Business Combination, description											The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.		The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.
Founder Shares [Member]
Payment received								$ 25,000
Shares price								$ 0.004
Ordinary share par value								$ 0.0001
Ordinary shares, issued								5,750,000
Weighted average capitalizations shares					1,150,000
Trading day, description								if (1) the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination which results in the Company’s shareholders having the right to exchange their shares for cash, securities or other property, the Founder Shares will be released from the lock-up.
Founder Shares [Member] | Director [Member]
Shares transferred to related party		13,000				718,750
Shares Purchase price						$ 3,125
Number of founder shares holding		6,002,500			862,500
Founder Shares [Member] | Sponsor [Member]
Number of founder shares holding	6,002,500		6,002,500			5,031,250							6,015,500
Founder Shares [Member] | Sponsor [Member] | Over-Allotment Option [Member]
Number of shares forfeited, unexercised by underwriters					900,000								900,000
Founder Shares [Member] | Ross Haghighat [Member]
Stock Issued During Period, Shares, New Issues													22,000
Administrative Support Agreement [Member]
Incurred administrative services									$ 30,000	$ 45,714	$ 60,000	$ 15,714	$ 105,862
Administrative Support Agreement [Member] | Office Space [Member]
Sponsor monthly payment				$ 10,000							10,000
Administrative Support Agreement [Member] | Utilities Secretarial [Member]
Sponsor monthly payment											10,000		10,000
Administrative Support Agreement [Member] | Administrative Support Service [Member]
Sponsor monthly payment											10,000		10,000
Working Capital Loan [Member]
Convertible debt	$ 1,500,000		$ 1,500,000						$ 1,500,000		$ 1,500,000		$ 1,500,000
Conversion Price	$ 1		$ 1						$ 1		$ 1		$ 1
Other Borrowings	$ 0		$ 0						$ 0		$ 0		$ 0		$ 0

Commitments & Contingencies - A

Commitments & Contingencies - Additional Information (Detail) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Sale of stock price per share	$ 10	$ 10
Deferred underwriting fees payable	$ 9,660,000	$ 9,660,000
Underwriting Agreement [Member]
Cash paid underwriting discount	$ 5,520,000	$ 5,520,000
Sale of stock price per share	$ 0.20	$ 0.20
Sale of stock, shares issued	27,600,000	27,600,000
Deferred fee underwriters price per units	$ 0.35	$ 0.35
Proceeds from deferred fee underwriters sold in public offering	24,000,000	24,000,000
Proceeds from deferred fee underwriters	$ 8,400,000	$ 8,400,000
Deferred underwriting fees payable	$ 9,660,000	$ 9,660,000
Over-Allotment Option [Member] | Underwriting Agreement [Member]
Sale of stock, shares issued	3,600,000	3,600,000
Proceeds from deferred fee underwriters	$ 1,260,000	$ 1,260,000

Recurring Fair Value Measurem_3

Recurring Fair Value Measurements - Additional Information (Detail) - USD ($)	6 Months Ended	12 Months Ended	16 Months Ended
	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2020
Investments held in Trust Account	$ 277,859,656	$ 277,845,876	$ 277,845,876
Amount withdraw from interest earned on the trust account		0
Transfers between levels	0		0
Money Market Funds [Member]
Investments held in Trust Account	$ 277,859,656	$ 277,845,876	$ 277,845,876

Recurring Fair Value Measurem_4

Recurring Fair Value Measurements - Schedule of Recurring Fair Values Investments Quoted Price in Active Markets for identical Assets (Detail) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Assets:
Investments held in Trust Account	$ 277,859,656	$ 277,845,876
Liabilities:
Warrant Liability	22,975,200	36,620,000
Fair Value, Net Asset (Liability)	22,975,200	36,620,000
Financial Liabilities Fair Value Disclosure		36,620,000
Public Warrants [Member]
Liabilities:
Warrant Liability	14,628,000	23,460,000
Public Warrants [Member] | Warrant liability [Member]
Liabilities:
Financial Liabilities Fair Value Disclosure		23,460,000
Private Warrants [Member]
Liabilities:
Warrant Liability	8,347,200	13,160,000
Private Warrants [Member] | Warrant liability [Member]
Liabilities:
Financial Liabilities Fair Value Disclosure		13,160,000
Money Market Funds [Member]
Assets:
Investments held in Trust Account	277,859,656	277,845,876
Quoted Prices In Active Markets (Level 1) [Member]
Assets:
Investments held in Trust Account	277,859,656	277,845,876
Liabilities:
Fair Value, Net Asset (Liability)	14,628,000	23,460,000
Financial Liabilities Fair Value Disclosure		23,460,000
Quoted Prices In Active Markets (Level 1) [Member] | Public Warrants [Member]
Liabilities:
Warrant Liability	14,628,000	23,460,000
Quoted Prices In Active Markets (Level 1) [Member] | Public Warrants [Member] | Warrant liability [Member]
Liabilities:
Financial Liabilities Fair Value Disclosure		23,460,000
Quoted Prices In Active Markets (Level 1) [Member] | Money Market Funds [Member]
Assets:
Investments held in Trust Account	277,859,656	277,845,876
Significant Other Unobservable Inputs (Level 3) [Member]
Liabilities:
Fair Value, Net Asset (Liability)	8,347,200	13,160,000
Financial Liabilities Fair Value Disclosure		13,160,000
Significant Other Unobservable Inputs (Level 3) [Member] | Public Warrants [Member] | Warrant liability [Member]
Liabilities:
Financial Liabilities Fair Value Disclosure
Significant Other Unobservable Inputs (Level 3) [Member] | Private Warrants [Member]
Liabilities:
Warrant Liability	$ 8,347,200	13,160,000
Significant Other Unobservable Inputs (Level 3) [Member] | Private Warrants [Member] | Warrant liability [Member]
Liabilities:
Financial Liabilities Fair Value Disclosure		13,160,000
Significant Other Unobservable Inputs (Level 3) [Member] | Money Market Funds [Member]
Assets:
Investments held in Trust Account

Recurring Fair Value Measurem_5

Recurring Fair Value Measurements - Summary of fair value measurements inputs (Detail)	Jun. 30, 2021yr	Dec. 31, 2020yr	Sep. 30, 2020yr	Jun. 30, 2020yr	Mar. 31, 2020yr	Feb. 13, 2020yr
Private Placement Warrants [Member] | Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.0099	0.0047	0.0035	0.0037	0.005	0.0148
Private Placement Warrants [Member] | Expected term (years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	5	5	5	5	5	5
Private Placement Warrants [Member] | Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0.170	0.220	0.210	0.150	0.17	0.220
Private Placement Warrants [Member] | Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	0	0	0	0	0	0
Private Placement Warrants [Member] | Exercise price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	11.50	11.50	11.50	11.50	11.5	11.5
Private Placement Warrants [Member] | Asset Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input	9.91	10.48	9.83	9.82	9.46	9.48
Public Warrant [Member] | Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input					0.005	0.0148
Public Warrant [Member] | Expected term (years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input					5	5
Public Warrant [Member] | Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input					0.170	0.220
Public Warrant [Member] | Dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input					0	0
Public Warrant [Member] | Exercise price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input					11.5	11.5
Public Warrant [Member] | Asset Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and Rights Outstanding, Measurement Input					9.46	9.48

Recurring Fair Value Measurem_6

Recurring Fair Value Measurements - Summary of Change in Fair Value of Warrant Liabilities (Detail) - Fair Value, Recurring [Member] - USD ($)	6 Months Ended	11 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	$ 36,620,000	$ 28,806,800
Change in valuation inputs or other assumptions	(12,428,400)	7,813,200
Ending balance	22,975,200	36,620,000
Private Placement Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	13,160,000	10,452,800
Change in valuation inputs or other assumptions	(4,812,800)	2,707,200
Ending balance	8,347,200	13,160,000
Public Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	23,460,000	18,354,000
Change in valuation inputs or other assumptions	(8,832,000)	5,106,000
Ending balance	$ 14,628,000	$ 23,460,000

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Detail) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2019
Ordinary shares subject to possible redemption	23,737,477	22,747,963
Conversion description	The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination on a one-for-one basis (as adjusted). In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by Public Shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.	The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination on a one-for-one basis (as adjusted). In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by Public Shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.
Percentage conversion of common shares outstanding	20.00%	20.00%
Preferred shares, shares authorized	1,000,000	1,000,000	1,000,000
Preferred shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred shares, shares Issued	0	0	0
Preferred shares, shares outstanding	0	0	0
Class A Common Stock
Ordinary shares, authorized	200,000,000	200,000,000	200,000,000
Ordinary shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
Ordinary shares, issued	3,862,523	4,852,037	0
Ordinary shares, outstanding	3,862,523	4,852,037	0
Ordinary shares subject to possible redemption	23,737,477	22,747,963	0
Class B common stock
Ordinary shares, authorized	20,000,000	20,000,000	20,000,000
Ordinary shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
Ordinary shares, issued	6,900,000	6,900,000	6,900,000
Ordinary shares, outstanding	6,900,000	6,900,000	6,900,000
Voting rights	Holders are entitled to one vote for each share of Class B ordinary shares	Holders are entitled to one vote for each share of Class B ordinary shares.

Subsequent Events - Additional

Subsequent Events - Additional Informtion (Detail)	Feb. 10, 2021shares
Mr Segall [Member] | Founder Shares [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Shares, Issued	13,000